Global Medical REIT (GMRE) director Henry Cole to leave board at 2026 meeting

Rhea-AI Filing Summary

Global Medical REIT Inc. reported that director Henry Cole has informed the Board that he intends to step down as a director, effective at the Company’s 2026 Annual Meeting of Stockholders. He will not be nominated for re-election, and his service will end when his current term expires on the date of that meeting.

The Company states that Mr. Cole’s decision to step down is not due to any disagreement with Global Medical REIT Inc. on matters related to its operations, policies, or practices, indicating an orderly and planned board transition rather than a dispute-driven change.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Understanding 8-K Material Events →

false 0001533615 0001533615 2026-01-23 2026-01-23 0001533615 us-gaap:CommonStockMember 2026-01-23 2026-01-23 0001533615 us-gaap:SeriesAPreferredStockMember 2026-01-23 2026-01-23 0001533615 us-gaap:WarrantMember 2026-01-23 2026-01-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE 

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): January 26, 2026 (January 23, 2026)

Global Medical REIT Inc.

(Exact name of registrant as specified in its charter)

Maryland	001-37815	46-4757266
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

7373 Wisconsin Avenue, Suite 800

Bethesda, MD

20814

(Address of Principal Executive
Offices)

(Zip Code)

(202) 524-6851

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:		Trading Symbols:		Name of each exchange on which registered:
Common Stock, par value $0.001 per share		GMRE		NYSE
Series A Preferred Stock, par value $0.001 per share		GMRE PrA		NYSE
Series B Preferred Stock, par value $0.001 per share		GMRE PrB		NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 23, 2026, Mr. Henry Cole notified the Board of Directors (the “Board”) of Global Medical REIT Inc. (the “Company”) that he intends to step down as a director of the Company, effective as of the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”). Accordingly, Mr. Cole will not be nominated by the Board for election as a director at the Annual Meeting, and Mr. Cole’s position as a director will end when his current term expires on the date of the Annual Meeting. Mr. Cole’s decision to step down was not a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practice.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Global Medical REIT Inc.
	By:	/s/ Jamie A. Barber
		Jamie A. Barber
		Secretary and General Counsel

Date: January 26, 2026

FAQ

What board change did Global Medical REIT Inc. (GMRE) disclose in this 8-K?

Global Medical REIT Inc. disclosed that director Henry Cole intends to step down from the Board, effective as of the Company’s 2026 Annual Meeting of Stockholders, and will not be nominated for re-election.

When will Henry Cole’s term as a Global Medical REIT (GMRE) director end?

Henry Cole’s term as a director will end on the date of Global Medical REIT Inc.’s 2026 Annual Meeting of Stockholders, when his current term expires.

Is Henry Cole leaving Global Medical REIT (GMRE) because of a disagreement with the company?

No. The company states that Mr. Cole’s decision to step down was not a result of any disagreement with Global Medical REIT Inc. regarding its operations, policies, or practices.

Will Henry Cole be nominated for re-election to the Global Medical REIT (GMRE) board?

No. The Board of Global Medical REIT Inc. will not nominate Henry Cole for election as a director at the 2026 Annual Meeting of Stockholders.

What securities of Global Medical REIT Inc. (GMRE) are listed on the NYSE?

Global Medical REIT Inc. lists its Common Stock, Series A Preferred Stock, and Series B Preferred Stock on the NYSE.

Who signed the Global Medical REIT (GMRE) 8-K reporting Henry Cole’s planned departure?

The report was signed on behalf of Global Medical REIT Inc. by Jamie A. Barber, who is the Company’s Secretary and General Counsel.